Pierre Giglio to Celecoxib
This is a "connection" page, showing publications Pierre Giglio has written about Celecoxib.
Connection Strength
0.165
-
Cyclooxygenase-2 inhibitors in glioma therapy. Am J Ther. 2004 Mar-Apr; 11(2):141-3.
Score: 0.058
-
Toxic epidermal necrolysis due to administration of celecoxib (Celebrex). South Med J. 2003 Mar; 96(3):320-1.
Score: 0.054
-
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma. Neuro Oncol. 2015 Feb; 17(2):266-73.
Score: 0.030
-
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma. Neuro Oncol. 2010 Nov; 12(11):1167-72.
Score: 0.023